Get in Touch

Empowering Transparency, Building Trust

Insight-driven tools and reports for informed decisions.

Explore DocumentsContact Investor Relations

Investor Documents & Resources

Access our library of financial reports, presentations, and regulatory filings

Annual Report 2024

PDF • 5.1 MB

Performance & Strategic Review for the fiscal year 2024.

Download

Q1 2024 Financial Highlights

PDF • 2.1 MB

First quarter financial performance and market analysis.

Download

Audited Financial Statements 2023

PDF • 3.8 MB

Complete set of audited financial statements for 2023.

Download

Frequently Asked Questions

Find answers to common investor inquiries

You can request custom investment briefs via our Contact page. Please include your investment profile and areas of interest for a tailored response.
Registered investors can access financial statements through our secure investor portal. Please contact our team to set up your account and receive login credentials.
Our investments are classified into three risk categories: Conservative (low risk, stable returns), Balanced (moderate risk, balanced returns), and Growth (higher risk, potential for higher returns). Each investment opportunity includes a detailed risk assessment.

Need More Information?

Our Investor Relations team is here to help with any questions you may have.

Contact Investor Relations

Epiidosis Investments L.L.C (DED Commercial License No. 896592, Register No. 1982638, DCCI No. 341676) operates solely as a principal investor, enterprise owner, and project operator under its Dubai Department of Economy and Tourism mainland commercial license. The company is licensed exclusively for investment in, establishment of, and management of enterprises across commercial, industrial, agricultural, tourism, energy, healthcare, education, and oil & gas sectors.

All materials on this website are informational and intended for qualified counterparties coordinating private operating mandates. This website does not constitute an offer, solicitation, or advertisement for any securities, financial products, or regulated services. Epiidosis does not solicit public investment, manage third-party capital, provide investment advisory or brokerage services, or conduct any activity requiring SCA, DFSA, or FSRA authorization.

Any engagement requires bilateral non-disclosure agreements, compliance clearance, and confirmation that accessing this content is lawful in the relevant jurisdiction.